BIIB

Biogen Inc. · Healthcare · Drug Manufacturers - General
$212.55
+3.40 (+1.63%)
Mkt Cap: 31.41B
Key Metrics
MetricValue
P/E RatioN/A
EV/EBITDAN/A
ROEN/A
Gross MarginN/A
Revenue GrowthN/A
FCF Yield7.9%
Dividend YieldN/A
Market Cap31.41B
Volume694.0K
Recent News
Biogen Completes Acquisition of RayThera Inc.
globenewswire.com · 2026-08-06
Biogen Inc. $BIIB Shares Acquired by Amundi
defenseworld.net · 2026-08-01
Why Biogen Stock Topped the Market Today
fool.com · 2026-07-29
Biogen Inc. (BIIB) Q2 2026 Earnings Call Transcript
seekingalpha.com · 2026-07-29
Biogen Boosts Profit Forecast with Growth Across Alzheimer's, Rare Disease Portfolio
benzinga.com · 2026-07-29
Q2 Earnings Season in Full Swing
zacks.com · 2026-07-29

Unlock the Full Deep Scan

9 AI agents analyze BIIB across earnings, insider flow, macro conditions, corporate strategy, market microstructure, and price action.

Sign Up Free →